Search

everythinglearnresearchcommunity

for

Search:↓

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

Lifestyle changes and insulin-sensitizing drugs are effective for managing PCOS.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Human skin can produce steroids from cholesterol.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

M50054 may help treat hepatitis and hair loss from chemotherapy.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

New hybrid compound found to effectively prevent hair loss.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.